JINTELI
Live / Registered — Registered and renewed (as of 14 Jul 2021)
What this means for you
Registered since 12 Apr 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Apr 2021).
Record
- Serial number
- 77774549
- Registration number
- 3945110
- Mark type
- Stylized text
- Filed
- 06 Jul 2009
- Published for opposition
- 15 Dec 2009
- Registered
- 12 Apr 2011
- Next maintenance due
- 12 Apr 2021
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Hormones
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prosecution history
- 18 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Nov 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Jul 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Jul 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Jul 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Jul 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Apr 2021 — TEAS SECTION 8 & 9 RECEIVED
- 12 Apr 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 28 Apr 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 28 Apr 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.